Questions concerning the use of family disease history and genetic tes
ting in breast carcinoma patients have brought medical issues to the c
ourts. Judicial answers with regard to the necessity for family histor
y elucidation and the at risk status of asymptomatic carriers of genes
associated with heritable disease have been recently recorded and are
presented in this article. (C) 1997 American Cancer Society.